44.210.77.106
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Thyroid Eye Disease

Teprotumumab may lower IOP in patients with thyroid eye disease

Treatment with teprotumumab is associated with a reduction in intraocular pressure (IOP) in patients with thyroid eye disease (TED), according to a study. In this retrospective review, the IOP, extent of proptosis, and clinical activity score of 17 patients (34 eyes) with TED who were treated with teprotumumab were analyzed...

Read More
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-